Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002276381 | SCV002563172 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | RB1: BP4, BP7 |
Ambry Genetics | RCV002443288 | SCV002733319 | likely benign | Hereditary cancer-predisposing syndrome | 2019-08-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004005579 | SCV004844731 | likely benign | Retinoblastoma | 2023-08-15 | criteria provided, single submitter | clinical testing |